Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - IDCW Option
Category: Index Fund
Launch Date: 26-10-2020
AUM:
₹ 140.89 Cr
Expense Ratio
1.04%
Benchmark
NIFTY 100 Equal Weight TRI
ISIN
INF754K01LS1
Minimum Investment
100.0
Minimum Topup
100.0
Minimum SIP Amount
500
Fund Manager
Bhavesh Jain, Amit Vora
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - IDCW Option | 38.51 | 12.32 | - |
| NIFTY 100 Equal Weight TRI | 47.26 | 20.96 | 20.28 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
16.9656
Last change
0.18 (1.0616%)
Fund Size (AUM)
₹ 140.89 Cr
Performance
16.19% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
Fund Manager
Bhavesh Jain, Amit Vora
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 13.78 |
| Cipla Ltd. | 7.02 |
| Dr. Reddy's Laboratories Ltd. | 6.92 |
| Max Healthcare Institute Ltd. | 6.24 |
| Apollo Hospitals Enterprise Ltd. | 5.72 |
| Eli Lilly And Co | 5.01 |
| Divi's Laboratories Ltd. | 4.57 |
| Lupin Ltd. | 3.58 |
| Novo Nordisk A/S - ADR | 3.14 |
| Aurobindo Pharma Ltd. | 2.91 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.97 |
| Others | 0.03 |